Profound Medical Corp. (PROF)
NASDAQ: PROF · IEX Real-Time Price · USD
7.99
+0.29 (3.77%)
At close: Apr 24, 2024, 3:59 PM
7.80
-0.19 (-2.38%)
After-hours: Apr 24, 2024, 4:00 PM EDT

Profound Medical Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Cash & Equivalents
26.2146.5267.1583.9114.830.6911.1
Cash & Cash Equivalents
26.2146.5267.1583.9114.830.6911.1
Cash Growth
-43.65%-30.73%-19.97%466.98%-51.77%176.38%-
Receivables
7.296.345.037.433.132.694.25
Inventory
6.997.947.415.333.673.631.43
Other Current Assets
1.411.22-2.471.071.210.910.82
Total Current Assets
41.962.0277.1397.7422.8137.9217.6
Property, Plant & Equipment
1.531.721.92.282.221.211.73
Goodwill and Intangibles
0.490.684.124.585.037.428.55
Other Long-Term Assets
003.620000
Total Long-Term Assets
2.022.49.656.867.258.6310.28
Total Assets
43.9164.4286.78104.630.0646.5527.88
Accounts Payable
3.282.033.183.383.033.915.08
Deferred Revenue
1.451.241.351.441.140.690.24
Current Debt
2.360.760.250.314.161.344.7
Other Current Liabilities
-0.730.16-0.63-0.32-0.111.940.59
Total Current Liabilities
6.374.194.164.818.227.8810.62
Long-Term Debt
5.587.471.131.366.8110.620.44
Other Long-Term Liabilities
0.790.760.881.080.651.432.68
Total Long-Term Liabilities
6.378.2322.447.4712.043.12
Total Liabilities
12.7312.426.167.2515.6919.9213.74
Total Debt
7.948.231.381.6810.9711.965.15
Debt Growth
-3.51%497.68%-17.84%-84.72%-8.23%132.36%-
Retained Earnings
-217.93-189.36-160.69-129.99-108.37-111.03-90.27
Comprehensive Income
12.0316.844.754.577.37-0.03-0.06
Shareholders' Equity
31.185280.6297.3514.3726.6314.14
Net Cash / Debt
18.2738.2965.7882.243.8318.735.96
Net Cash / Debt Growth
-52.28%-41.79%-20.02%2047.74%-79.56%214.39%-
Working Capital
35.5357.8472.9792.9314.5830.046.99
Book Value Per Share
1.462.493.884.961.212.25-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).